New studies have revealed that even a short 10-minute exercise session is enough to increase the number of immune cells in the bloodstream which helps to destroy cancer cells in cancer patients.
Just 10 minutes of cycling or walking to a supermarket can be enough to boost the body’s immune system.
(Source: Pixabay)
Turku/Finland – Exercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients’ quality of life and the prognosis of cancer patients. “It was previously thought that cancer patients should just rest after a cancer diagnosis. Today, we have more and more researched information that exercise can even improve the prognosis of cancer. However, it is not yet fully known how exercise controls cancer,” explains Research Assistant Tiia Koivula.
Previous preclinical studies have found that exercise affects the functioning of the immune system so that more immune cells are transferred to the tumor site and they become more active in destroying cancer cells. Two studies conducted at the Turku Pet Centre of the University of Turku in Finland aimed to find out whether a short exercise bout affects the mobilization of immune cells in cancer patients.
Only 10-minute exercise was enough
The two studies involved 28 recently-diagnosed lymphoma and breast cancer patients. The lymphoma patients were between the ages of 20 and 69 and the breast cancer patients between the ages of 37 and 73. During the study, the patients did a 10-minute exercise on bicycle. Blood samples were taken once before the exercise and twice after the exercise.
“The pedaling resistance was determined individually for each patient so that it corresponded to light or moderate physical activity. The most important goal was that the patients were able to pedal for 10 minutes straight without exhaustion, but so that their heart rate increased,” Koivula describes. The researchers analyzed the number of several different immune cells, which are also known as white blood cells, from the blood samples and compared the numbers in samples before and after the exercise.
Exercise increased the number of immune cells capable of destroying cancer cells
During the exercise, cytotoxic T cells and natural killer cells increased in the bloodstream of lymphoma patients. In breast cancer patients, the exercise also increased the total number of white blood cells, as well as the number of intermediate monocytes and B cells in addition to the cytotoxic T cells and natural killer cells. The change was quick and transient and, in most of the patients, the number of immune cells returned to a level corresponding to the resting value in the blood samples that were taken 30 minutes after the end of the exercise.
“It is especially interesting that we saw an increase in cytotoxic immune cells during the exercise in both patient groups. These immune cells are capable of destroying cancer cells,” Koivula notes.
The researchers also found a link between the intensity of exercise and the change in the number of immune cells in both patient groups. The more the patients’ heart rate and blood pressure increased, the more immune cells were transferred into the bloodstream.
“Although our results indicate that the higher the exercise intensity is, the more immune cells are transferred from their storage organs into the bloodstream, it is notable that also light or moderate intensity exercise lasting for only 10 minutes will cause an increase in the number of immune cells which are important for fighting cancer,” Koivula encourages.
Koivula says that it is important for patients to find a physical exercise that they enjoy. “Cancer treatments can make you tired and lower your motivation for exercise, which is why it is comforting to know that just 10 minutes of cycling or walking to a supermarket, for example, can be enough to boost the body’s immune system.”
Does exercise transfer immune cells to the tumor?
Tiia Koivula states that, based on the studies, it is not yet known where the immune cells enter the bloodstream and where they go after the exercise.
“Further research in cancer patients is needed to study whether the immune cells are transported to the tumor after the exercise, where they could destroy cancer cells. This has been shown to happen in preclinical studies, but research in cancer patients is still rather incomplete,” Koivula says.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
Cancer treatments often affect the immune defense by reducing the number of immune cells. When the immune system weakens, the boosting role of exercise can be especially important. Koivula's immunological studies are part of a larger research project of Academy Research Fellow Ilkka Heinonen supported by the Academy of Finland and the Hospital District of Southwest Finland to investigate the effects of exercise on cancer. The studies were carried out in collaboration with doctors and researchers from the University of Turku and the Cancer Clinic of Turku University Hospital, who also operate at the Turku Immunology Centre and the Inflames flagship. Researchers from Karolinska Institutet in Stockholm were also involved in the studies.
The studies were published in Frontiers in Physiology – Clinical and Translational Physiology and Scientific Reports journals in January and April 2023.